BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23068147)

  • 1. Cryptococcosis.
    Negroni R
    Clin Dermatol; 2012; 30(6):599-609. PubMed ID: 23068147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary cryptococcosis.
    Brizendine KD; Baddley JW; Pappas PG
    Semin Respir Crit Care Med; 2011 Dec; 32(6):727-34. PubMed ID: 22167400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
    Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
    Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
    BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
    Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y
    Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion.
    Tilak R; Prakash P; Nigam C; Tilak V; Gambhir IS; Gulati AK
    Dermatol Online J; 2009 Sep; 15(9):12. PubMed ID: 19930999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of cutaneous cryptococcosis.
    Xiujiao X; Ai'e X
    Mycoses; 2005 Jul; 48(4):238-41. PubMed ID: 15982204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic fungal infections in patients with human inmunodeficiency virus.
    Rodríguez-Cerdeira C; Arenas R; Moreno-Coutiño G; Vásquez E; Fernández R; Chang P
    Actas Dermosifiliogr; 2014; 105(1):5-17. PubMed ID: 23107866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
    Chen SC; Korman TM; Slavin MA; Marriott D; Byth K; Bak N; Currie BJ; Hajkowicz K; Heath CH; Kidd S; McBride WJ; Meyer W; Murray R; Playford EG; Sorrell TC;
    Clin Infect Dis; 2013 Aug; 57(4):543-51. PubMed ID: 23697747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryptococcosis].
    Yoshida K; Shoji H; Niki Y
    Nihon Rinsho; 2008 Dec; 66(12):2350-5. PubMed ID: 19069104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
    Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E;
    Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
    Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
    Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous cryptococcosis caused by Cryptococcus gattii in an immunocompetent host.
    Leão CA; Ferreira-Paim K; Andrade-Silva L; Mora DJ; da Silva PR; Machado AS; Neves PF; Pena GS; Teixeira LS; Silva-Vergara ML
    Med Mycol; 2011 May; 49(4):352-5. PubMed ID: 21028946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cryptococcus species--etiological agents of zoonoses or sapronosis?].
    Blaschke-Hellmessen R
    Mycoses; 2000; 43 Suppl 1():48-60. PubMed ID: 11098627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryptococcus neoformans meningitis in a HIV negative miliary tuberculosis-suspected patient].
    Aydemir H; Pişkin N; Oztoprak N; Celebi G; Tekin IO; Akduman D
    Mikrobiyol Bul; 2008 Jul; 42(3):519-24. PubMed ID: 18822899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.